Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2012
02/15/2012EP2417130A2 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
02/15/2012EP2417123A2 Therapeutic compositions and related methods of use
02/15/2012EP2417122A1 Indole derivatives and methods for antiviral treatment
02/15/2012EP2417119A2 No-carrier-added nucleophilic ýf-18¨fluorination of aromatic compounds
02/15/2012EP2417112A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
02/15/2012EP2417108A1 Organic compounds and their uses
02/15/2012EP2170831B1 Benzazepine derivatives useful as vasopressin antagonists
02/15/2012EP2027107B1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
02/15/2012EP1797077B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
02/15/2012CN102356078A Novel method for producing enaminocarbonyl compounds
02/15/2012CN102356077A Novel method for producing enaminocarbonyl compounds
02/15/2012CN102351850A Method for refining itraconazole
02/15/2012CN102351849A Preparation method of olmesartan medoxomil
02/15/2012CN102351769A Chiral 2,5-pyrroline derivative, and synthetic method and biological activity thereof
02/15/2012CN102349873A Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof
02/15/2012CN101863839B N-3-芳酰胺-5-环丙烷螺环乙内酰脲衍生物及其制备方法和应用 N-3- aramid -5- cyclopropane spiro hydantoin derivatives, preparation method and application
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114997 N4-acylcytosine nucleosides for treatment of viral infections
02/14/2012US8114991 Used for the control of a range of harmful weeds
02/14/2012US8114884 CXCR4 antagonists for the treatment of medical disorders
02/14/2012US8114879 Piperazine derivatives useful as CCR5 antagonists
02/14/2012CA2651653C 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/09/2012WO2012018325A1 Hepatitis c virus inhibitors
02/09/2012WO2012018235A2 Method for preparing decitabine with improved yield and purity
02/09/2012WO2012017948A1 Epoxy compound with nitrogen-containing ring
02/09/2012WO2012017894A1 Method for producing epoxy compound having cyanuric acid skeleton
02/09/2012WO2012017891A1 Pyridyl benzofuran derivative
02/09/2012WO2012017448A2 Salts of lapatinib
02/09/2012WO2012017020A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
02/09/2012WO2012016993A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
02/09/2012WO2011106992A8 Inhibitors of hepatitis c virus ns5b polymerase
02/09/2012US20120035407 Compounds useful as inhibitors of atr kinase
02/09/2012US20120035361 Selective inhibitors of excitatory amino acid transporter subtype 1 (eaat1/glast)
02/09/2012US20120035351 Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors
02/09/2012US20120035255 Derivative of [(3-hydroxy-4 pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
02/09/2012US20120035210 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
02/09/2012US20120035200 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
02/09/2012US20120035194 Substituted 2-amino-fused heterocyclic compounds
02/09/2012US20120035173 Di-substituted amides for enhancing glutamatergic synaptic responses
02/09/2012US20120035170 Novel unsaturated tetracyclic tetrahydrofuran derivatives
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035157 2-pyridone derivatives as neutrophil elastase inhibitors and their use
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035149 Prokineticin Receptor Antagonists And Uses Thereof
02/09/2012US20120035141 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
02/09/2012US20120035131 Pyrazoline compounds
02/09/2012US20120035053 Novel herbicides
02/09/2012US20120034270 S1P Receptors Modulators
02/09/2012CA2807305A1 Hepatitis c virus inhibitors
02/09/2012CA2807198A1 Ligands for antibody and fc-fusion protein purification by affinity chromatography
02/09/2012CA2806015A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
02/08/2012EP2415764A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
02/08/2012EP2415763A1 Pharmaceutical composition for treating or preventing glaucoma
02/08/2012EP2415756A1 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity
02/08/2012EP2414350A1 Hepatitis c virus inhibitors
02/08/2012EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors
02/08/2012EP2176251B1 5-pyridinone substituted indazoles and pharmaceutical compositions thereof
02/08/2012EP2148874B1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
02/08/2012EP2144898B1 Heterocyclic hydrazide compound and pesticidal use of the same
02/08/2012EP2121653B1 Carboxamide compounds and their use as calpain inhibitors
02/08/2012CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound
02/08/2012CN102348708A Prodrug forms of kinase inhibitors and their use in therapy
02/08/2012CN102348707A Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase
02/08/2012CN102348706A Process for producing pyripyropene derivative
02/08/2012CN102348698A Inhibitors of beta-secretase
02/08/2012CN102348686A Bis aromatic compounds for use as ltc4 synthase inhibitors
02/08/2012CN102344446A Cis-nitenpyram analog containing carboxylic acid-substituted methyl ester and preparation method and application thereof
02/08/2012CN102344445A Optical voidness quinazoline compound
02/08/2012CN102344444A Optically pure quinazoline compounds
02/08/2012CN101863823B 吲哚二酮类化合物及其扩环衍生物、制备方法及应用 Indole ring expansion diketones and derivatives, preparation method and application
02/08/2012CN101573337B 作为抗肿瘤剂的5、6或7-取代-3-(杂)芳基-异喹啉胺衍生物 5, 6 or 7 as an anti-tumor agent is a substituted 3- (hetero) aryl - isoquinoline derivatives of the amine
02/08/2012CN101522665B *庚英衍生物 * Geng Ying derivatives
02/08/2012CN101415687B 鞘氨醇-1-磷酸结合抑制物质 Sphingosine-1-phosphate binding-inhibiting substance
02/07/2012US8110688 Method for producing indole derivative having piperidine ring
02/07/2012US8110683 Piperidinyl compounds that selectively bind integrins
02/07/2012US8110678 Antibiotic-bound poly(caprolactone) polymer
02/07/2012US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
02/07/2012US8110574 Derivatives of 4-aminopiperidine and their use as a medicament
02/07/2012CA2663366C Compounds and compositions as protein kinase inhibitors
02/07/2012CA2648569C Pyridyl amide t-type calcium channel antagonists
02/07/2012CA2516514C Arylvinylazacycloalkane compounds and methods of preparation and use thereof
02/07/2012CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
02/07/2012CA2471044C Benzimidazole derivatives and their use as gnrh antagonists
02/07/2012CA2465594C Tagged microparticle compositions and methods
02/02/2012WO2012016217A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012WO2012016001A1 Cyclic amine azaheterocyclic carboxamides
02/02/2012WO2012015723A1 Sulfonamide compounds useful as cyp17 inhibitors
02/02/2012WO2012015324A1 Process for the synthesis of substituted urea compounds
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014963A1 Condensed ring pyridine compound
02/02/2012WO2012014848A1 Flavoniod-derived hes-1 promoter inhibitor
02/02/2012WO2012014841A1 Organic electroluminescence element
02/02/2012WO2012014181A1 Novel derivatives useful as antiviral agents
02/02/2012WO2012013727A1 Cyclopropylamine derivatives useful as lsd1 inhibitors
02/02/2012WO2012013716A1 Bicyclic acetyl-coa carboxylase inhibitors
02/02/2012WO2012012941A1 Bcl-2 family protein inhibitors, their cyclodextrin inclusion compounds, complexes, and uses in manufacture of bcl-2 family protein inhibitors thereof
02/02/2012WO2011130419A3 Broad spectrum antiviral and antiparasitic agents
02/02/2012WO2011127388A3 Inverse agonists and neutral antagonists for the tsh receptor
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 694